CYTOKINE SERUM LEVELS AND ACUTE GRAFT VERSUS HOST-DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引:0
|
作者
TONG, J
VIALE, M
BACIGALUPO, A
PODESTA, M
SOGNO, G
TEDONE, E
MARMONT, AM
机构
[1] OSPED SAN MARTINO GENOVA,CTR TRAPIANTI MIDOLLO OSSEO,DIV EMATOL,GENOA,ITALY
[2] IST NAZL RIC CANC,FARMACOL TOSSICOL LAB,GENOA,ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:365 / 366
页数:2
相关论文
共 50 条
  • [41] Serum TNFα levels in patients with acute graft-versus-host disease after bone marrow transplantation
    Huang, XJ
    Wan, J
    Lu, DP
    LEUKEMIA, 2001, 15 (07) : 1089 - 1091
  • [42] Serum TNFα levels in patients with acute graft-versus-host disease after bone marrow transplantation
    XJ Huang
    J Wan
    DP Lu
    Leukemia, 2001, 15 : 1089 - 1091
  • [43] ABO COMPATIBILITY AND ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BACIGALUPO, A
    VANLINT, MT
    OCCHINI, D
    MARGIOCCO, M
    FERRARI, G
    PITTALUGA, PA
    FRASSONI, F
    PERALVO, J
    LERCARI, G
    CARUBIA, F
    MARMONT, AM
    TRANSPLANTATION, 1988, 45 (06) : 1091 - 1094
  • [44] CHEMOSEPARATION OF DONOR BONE-MARROW AS PREVENTION OF GRAFT VERSUS HOST-DISEASE
    ZANDER, AR
    YAU, J
    CHOW, H
    HUYNH, L
    VELLEKOOP, L
    CULBERT, S
    SPITZER, G
    DICKE, K
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 186 - 186
  • [45] MATERNAL LYMPHOCYTE ENGRAFTMENT IS ASSOCIATED WITH SEVERE GRAFT VERSUS HOST-DISEASE AFTER HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION
    NOYA, FJ
    GRUBER, RA
    SCHLACTUS, JL
    GUERRA, IC
    ROSENBLATT, HM
    BARRON, KS
    POLLACK, MS
    RITZ, J
    SHEARER, WT
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 236 - 236
  • [46] Kinetics of KIR transcripts correlates with acute graft-versus host-disease occurrence in allogeneic bone marrow transplantation
    Denis, L
    Gagne, K
    Gueglio, B
    Kerdudou, N
    Milpied, N
    Simon, P
    Follea, G
    Bonneville, M
    Harousseau, JL
    Bignon, JD
    GENES AND IMMUNITY, 2004, 5 : S3 - S3
  • [47] SYNGENEIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION AND CYCLOSPORINE TREATMENT
    HESS, AD
    VOGELSANG, GB
    SILANSKIS, M
    FRIEDMAN, KA
    BESCHORNER, WE
    SANTOS, GW
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (03) : 487 - 492
  • [48] CHRONIC GRAFT-VERSUS-HOST DISEASE CGVHD IN CHILDREN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SCHMITT, C
    BORDIGONI, P
    WITZ, F
    OLIVE, D
    MAYEUX, D
    BONE MARROW TRANSPLANTATION, 1988, 3 : 228 - 228
  • [49] USE OF CYCLOSPORINE FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GLUCKMAN, E
    DEVERGIE, A
    LOKIEC, F
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (03) : 461 - 469
  • [50] A CLINICOPATHOLOGICAL STUDY OF 15 AUTOPSY CASES WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION IN SPECIAL REFERENCE TO GRAFT VERSUS HOST-DISEASE (GVHD)
    NAKAMURA, N
    ACTA PATHOLOGICA JAPONICA, 1986, 36 (05): : 641 - 664